Omeros Elevated By Medicare Reimbursement And OMS721 Progress, Says Maxim

By: via Benzinga
Extended Medicare reimbursement for Omeros Corporation (NASDAQ: OMER)’s OMIDRIA,along with the company’s increased ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.